The three SPL submissions, the order that matters, what each one contains, and how to keep the listing from being rejected.
| # | Submission | What it does / contains |
|---|---|---|
| 1 | Establishment registration | Registers the facility — DUNS/FEI, operations, and (foreign) the U.S. Agent |
| 2 | Labeler code form | Requests the labeler code — the first segment of your NDC |
| 3 | Product listing | Lists the specific hand sanitizer — NDC, active & strength, dosage form, package, Drug Facts labeling |
The most common way a hand sanitizer listing fails is skipping the order. The product listing references your establishment (by DUNS/FEI) and your labeler code (the NDC's first segment) — so both must exist and be active before the listing will validate.
FDA Registration Assistance runs the whole workflow — establishment registration (with U.S. Agent for foreign firms), the labeler code, and the NDC product listing in SPL, with the active/strength, Drug Facts label, and package data coded correctly so it validates — plus cGMP and OMUFA guidance and annual renewal. If a prior listing was rejected, we diagnose and fix it.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
Because hand sanitizer is an OTC drug, getting it to market is a drug registration-and-listing workflow made of three SPL (Structured Product Labeling) submissions: (1) establishment registration for the manufacturing facility; (2) a labeler code, which becomes the first segment of your NDC; and (3) the product listing, which registers the specific product with its NDC. Each is submitted electronically and validated by FDA. Registration identifies the facility; listing identifies the product.
Yes - it's regulated as an OTC drug (a topical consumer antiseptic rub) because "kills germs / reduces bacteria" is a drug claim, not a cosmetic one. That's why the registration-and-listing workflow applies at all. If you want the full explanation of why it's a drug, which active ingredients are eligible, and the methanol/import issues, see our companion page on whether hand sanitizer requires FDA registration.
First, establishment registration: the facility's SPL, with its DUNS/FEI, operations, and - for foreign facilities - a U.S. Agent. Second, the labeler code form: an SPL that requests the labeler code identifying your firm (the first part of the NDC). Third, the product listing: the SPL for the specific hand sanitizer, with its NDC, active ingredient and strength, dosage form, package description, and labeling. They build on each other, so order matters.
The listing SPL captures the product's structured data: the active ingredient and its strength (e.g., "Ethyl alcohol 70% v/v") with its unique ingredient identifier, the dosage form and route, inactive ingredients, the package/NDC configuration, and the content of labeling (the Drug Facts panel and a labeling image). All of it has to be coded to FDA's controlled vocabularies and match the label - mismatches cause the listing to be rejected.
Yes - that dependency is the key thing to get right. The product listing references your establishment (by DUNS/FEI) and your labeler code (the first segment of the NDC), so both must exist and be active before the listing will validate. Trying to list a product before the establishment is registered and the labeler code is assigned - or with a DUNS that doesn't match - is a leading cause of listing rejections.
For a monograph hand sanitizer, only three actives are eligible: ethyl alcohol (ethanol), isopropyl alcohol, and benzalkonium chloride. Twenty-eight others (including triclosan) are not eligible and would require an NDA. Your listing must reflect an eligible active at a permitted strength. We cover the eligible-ingredient rules in detail on the companion classification page - here the point is that the listing has to declare a compliant active.
Yes, with one addition: a foreign establishment must designate a U.S. Agent (21 CFR 207.69) as part of the establishment registration. The rest of the workflow - labeler code, product listing, Drug Facts label, cGMP - is the same. The U.S. Agent must consent, and its designation is part of a valid registration, so it needs to be in place for the listing to stand on a valid foundation.
The labeler code identifies the firm marketing the product and forms the first segment of the NDC. You request it via its own SPL submission, and FDA assigns it. You need it before the product listing, because the listing's NDC is built on the labeler code. Sequencing it first avoids a listing that can't validate for lack of a labeler code.
A compliant Drug Facts panel (21 CFR 201.66): active ingredient and strength, purpose (antiseptic), use, warnings (flammable, external use only, do not use in eyes, keep out of reach of children, do not ingest), directions, and inactive ingredients. The labeling in the SPL listing must match the physical label. Because hand sanitizer's warnings are specific, the label is a common failure point - review it before submitting.
Yes to both. OTC monograph drug manufacturers - including hand sanitizer makers - pay the annual OMUFA facility fee. And drug establishment registration renews annually, October–December (21 CFR 207.29), with drug listings kept current. A lapse makes the product misbranded and can inactivate the listing, so the workflow includes maintenance, not just the initial submissions.
Read FDA's validation acknowledgment - it names the specific errors. Common ones are a labeler-code/DUNS mismatch, an establishment that isn't registered, document-tracking or structured-data errors (dosage form, active strength), and labeling that doesn't match the SPL. Fix every error, confirm the registration and labeler code are in place, re-validate, and resubmit. We have a dedicated guide to fixing a rejected drug listing.
Yes. As an OTC drug, hand sanitizer must be made under cGMP (21 CFR 210/211), which underpins consistent alcohol potency and testing to rule out methanol and other contaminants. The registration/listing workflow assumes the product is made under cGMP; a product that isn't is adulterated regardless of a clean listing.
It depends on how ready the inputs are - DUNS/FEI, the eligible active and formula, the Drug Facts label, and (for foreign firms) the U.S. Agent. The SPL submissions themselves are electronic and validated by FDA; the time-consuming part is usually getting the label and product data right so the listing validates on the first attempt rather than bouncing. Preparing everything before submitting is the way to avoid a rejection cycle.
No. Registration identifies the facility, listing identifies the product, and monograph compliance lets you market without an NDA - but none of these is FDA "approval." Claiming a hand sanitizer is "FDA-approved" because it's registered or listed is misbranding. It's compliance, not approval.
You can - SPL is submitted through FDA tools like CDER Direct - but the three submissions, their sequence and dependencies, the controlled vocabularies, and the Drug Facts label are technical, and first-timers often hit repeated rejections. If you want it validated on the first pass, or you're a foreign firm coordinating the U.S. Agent consent, expert handling is usually faster overall.
We run the whole workflow: establishment registration (with U.S. Agent for foreign firms), the labeler code, and the NDC product listing in SPL, with the active/strength, Drug Facts label, and package data coded correctly so it validates - plus cGMP and OMUFA guidance and annual renewal. If a prior listing was rejected, we diagnose and fix it. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.